DV
Devonian Health Group Inc.
DVHGF · OTC
$5.88 +0.00% (+$0.00)
1M +3.34%
Market Cap $23.2M
P/E Ratio -
Div. Yield -
ROE 77.36%
Bulios Fair Price
$3.39
42.3% downside
Current Price
$5.88
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DVHGF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
31 /100
Expensive P/S 8.80x
P/B 3.33x
P/E N/A
Growth
78 /100
Growing Rev. growth 94.75%
Book val. growth 26.00%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 58.11%
FCF margin 446.22%
Net margin 227.68%
Quality
4 /100
Poor ROIC 84.35%
Asset turnover 0.31x
ROE 77.36%
Debt
54 /100
Moderate Debt/Equity 0.02x
Int. coverage -866.62x
Current ratio 0.91x
Stability
15 /100
Unstable Beta 1.26x
Profitable years 0
Rev. volatility 381.61%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DVHGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Andre Boulet
Employees
8
Headquarters
Québec